Welcome to our dedicated page for Atomera SEC filings (Ticker: ATOM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Atomera Incorporated filings document the company's semiconductor technology licensing business, Nasdaq-listed common stock, and material-event disclosures. Current reports furnish quarterly and annual financial results, investor presentations, Regulation FD communications, and capital-structure information related to common stock and registered securities.
Proxy and governance filings cover annual meeting procedures, shareholder voting matters, board and bylaw provisions, and other corporate-governance disclosures. The record also includes amendments to bylaws, including meeting quorum and voting-requirement changes, alongside formal exhibits used to report operating results, material agreements, and other public-company events.
Atomera Incorporated (ATOM) Form 8-K — Aug 5, 2025
Atomera filed a Current Report on Form 8-K dated August 5, 2025, under Item 2.02 to announce its financial results for the three and six months ended June 20, 2025. The filing states a press release (Exhibit 99.1) and an investor presentation (Exhibit 99.2) are attached and incorporated by reference. The company says the information is furnished pursuant to Item 2.02 and expressly "shall not be deemed 'filed'" under the Exchange Act or incorporated by reference into other filings. The report is signed by CFO Francis B. Laurencio and lists the registrant address in Los Gatos, CA and a contact phone number.
Atomera Incorporated (ATOM) filed a Form S-8 on June 26, 2025 to register an additional 1,750,000 shares of common stock reserved for issuance under its 2023 Stock Incentive Plan, following stockholder approval on May 15, 2025.
The filing incorporates by reference the company’s Form 10-K for the year ended December 31, 2024, Form 10-Q for the quarter ended March 31, 2025, multiple Form 8-Ks, and other Exchange Act reports. Key exhibits include the legal opinion from Greenberg Traurig (Ex. 5.1), Marcum LLP’s auditor consent (Ex. 23.1), and the plan document (Ex. 99.1). The registration is routine and does not contain new financial results or strategic transactions.